Carl MANN

Dr. Carl MANN

orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1985 in Cell
Verified
Journal Article
Closed access
PHP Hieter
P Hieter
CMCarl MANN
Carl MANN
MSM Snyder
M Snyder
RDR W Davis
R W Davis

1 December 1993 in Nature
Verified
Journal Article
Closed access
MGMichel Ghislain
Michel Ghislain
AUAndor Udvardy
Andor Udvardy
CMCarl MANN
Carl MANN

1 June 1982 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DSDan T. Stinchcomb
Dan T. Stinchcomb
CMCarl MANN
Carl MANN
RDRonald W. Davis
Ronald W. Davis

1 April 2000 in Current Biology
Verified
Journal Article
Closed access
SMStéphane Marcand
Stéphane Marcand
VBVanessa Brevet
Vanessa Brevet
CMCarl MANN
Carl MANN
EGEric Gilson
Eric Gilson

10 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
KCKévin Contrepois
Kévin Contrepois
CCClément Coudereau
Clément Coudereau
BBBérénice A. Benayoun
Bérénice A. Benayoun
NSNadine Schuler
Nadine Schuler
PRPierre-François Roux
Pierre-François Roux
CMCarl MANN
Carl MANN
The senescence of mammalian cells is characterized by a proliferative arrest in response to stress and the expression of an inflammatory phenotype. Here we show that histone H2A.J, a poorly studied H2A variant found only in mammals, accumulates in human fibroblasts in senescence with persistent DNA damage. H2A.J also accumulates in mice with aging in a tissue-specific manner and in human skin. Knock-down of H2A.J inhibits the expression of inflammatory genes that contribute to the senescent-associated secretory phenotype (SASP), and over expression of H2A.J increases the expression of some of these genes in proliferating cells. H2A.J accumulation may thus promote the signalling of senescent cells to the immune system, and it may contribute to chronic inflammation and the development of aging-associated diseases.

15 February 1995 in Genes & Development
Verified
Journal Article
Open access
PDF file
YBY Barral
Y Barral
SJS Jentsch
S Jentsch
CMCarl MANN
Carl MANN
Entry into a new cell cycle is triggered by environmental signals at a point called Start in G1 phase. A key regulator of this transition step in yeast is the CDC28 kinase together with its short-lived regulatory subunits called G1-cyclins or CLN proteins. To identify genes involved in G1-cyclin degradation, we employed a genetic screen by selecting for stable CLN1-beta-galactosidase fusion proteins. Surprisingly, one group of mutants was found to be allelic to GRR1, a gene previously described to be involved in glucose uptake, glucose repression, and divalent cation transport. In grr1 mutants, both CLN1 and CLN2 cyclins are significantly stabilized. A suppressor analysis indicated that G1-cyclin stabilization in grr1 was not a consequence of the nutrient uptake defect. This suggests that the GRR1 gene product is part of a common regulatory pathway linking two functions important for cell growth, nutrient uptake, and G1 cyclin-controlled cell division.